Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Management of spasticity revisited.

Graham LA.

Age Ageing. 2013 Jul;42(4):435-41. doi: 10.1093/ageing/aft064. Review.

2.

[Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics].

Yelnik AP.

Ann Readapt Med Phys. 2004 Oct;47(8):575-89. Review. French.

PMID:
15465163
3.

Spasticity: a rehabilitation challenge in the elderly.

Barnes MP.

Gerontology. 2001 Nov-Dec;47(6):295-9. Review.

PMID:
11721141
4.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

5.

Treatment alternatives for spinal cord injury related spasticity.

Kirshblum S.

J Spinal Cord Med. 1999 Fall;22(3):199-217. Review.

PMID:
10685385
6.

Pharmacologic interventions for reducing spasticity in cerebral palsy.

Patel DR, Soyode O.

Indian J Pediatr. 2005 Oct;72(10):869-72. Review.

PMID:
16272661
7.

[Selection of treatment modalities in patients with spasticity].

Ota T.

Brain Nerve. 2014 Sep;66(9):1031-8. Japanese.

PMID:
25200574
8.

Spasticity following spinal cord injury.

Rekand T, Hagen EM, Grønning M.

Tidsskr Nor Laegeforen. 2012 Apr 30;132(8):970-3. doi: 10.4045/tidsskr.10.0872. Review. English, Norwegian.

9.

[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].

Wissel J, Entner T.

Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Review. German.

PMID:
15506048
10.

Clinical assessment and management of spasticity: a review.

Rekand T.

Acta Neurol Scand Suppl. 2010;(190):62-6. doi: 10.1111/j.1600-0404.2010.01378.x. Review.

PMID:
20586738
11.

Spasticity treatment with botulinum toxins.

Ward AB.

J Neural Transm (Vienna). 2008;115(4):607-16. doi: 10.1007/s00702-007-0833-2. Epub 2008 Apr 4. Review.

PMID:
18389166
12.

[Management of spasticity in children with cerebral palsy].

Matthews DJ, Balaban B.

Acta Orthop Traumatol Turc. 2009 Mar-Apr;43(2):81-6. doi: 10.3944/AOTT.2009.081. Turkish.

13.

Considerations in the treatment of spasticity with intrathecal baclofen.

Mullarkey T.

Am J Health Syst Pharm. 2009 Sep 1;66(17 Suppl 5):S14-22. doi: 10.2146/ajhp0108c. Review.

PMID:
19710446
14.

[Use of botulinum neurotoxin for spasticity].

Mukai Y, Kaji R.

Brain Nerve. 2008 Dec;60(12):1421-6. Review. Japanese.

PMID:
19110753
15.

Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.

Bensmail D, Ward AB, Wissel J, Motta F, Saltuari L, Lissens J, Cros S, Beresniak A.

Neurorehabil Neural Repair. 2009 Jul-Aug;23(6):546-52. doi: 10.1177/1545968308328724. Epub 2009 Feb 19.

PMID:
19228818
17.

Spasticity in adults living in a developmental center.

Pfister AA, Roberts AG, Taylor HM, Noel-Spaudling S, Damian MM, Charles PD.

Arch Phys Med Rehabil. 2003 Dec;84(12):1808-12.

PMID:
14669188
18.

Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.

Olvey EL, Armstrong EP, Grizzle AJ.

Clin Ther. 2010 Dec;32(14):2282-303. doi: 10.1016/j.clinthera.2011.01.005. Review.

PMID:
21353101
19.

Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations.

Borg-Stein J, Pine ZM, Miller JR, Brin MF.

Am J Phys Med Rehabil. 1993 Dec;72(6):364-8.

PMID:
8260129
Items per page

Supplemental Content

Write to the Help Desk